• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童和家长对慢性移植物抗宿主病(cGVHD)症状体验的看法:一项概念发掘研究。

Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study.

出版信息

Support Care Cancer. 2014 Feb;22(2):295-305. doi: 10.1007/s00520-013-1957-6.

DOI:10.1007/s00520-013-1957-6
PMID:24077685
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5176341/
Abstract

PURPOSE

Chronic graft-versus-host disease (cGVHD) is a significant cause of mortality and morbidity after allogeneic hematopoietic cell transplant and is associated with a wide range of distressing symptoms. A pediatric measure of cGVHD-related symptoms is needed to advance clinical research. Our aim was to elicit descriptions of the cGVHD symptom experience directly from children and to compare the specific language used by children to describe their symptoms and the comprehension of symptom concepts across the developmental spectrum.

METHODS

We used qualitative methods to identify the phrases, terms, and constructs that children (ages 5–8 [n =8], 9–12 [n =8], and 13–17 [n =8]) with cGVHD employ when describing their symptoms. The symptom experience of each participant was determined through individual interviews with each participant and parent (5–7 year olds were interviewed together with a parent). Medical practitioners with experience in evaluating cGVHD performed clinical assessments of each participant.

RESULTS

Pediatric transplant survivors and their parents identified a wide range of bothersome cGVHD symptoms, and common concepts and terminologies to describe these experiences emerged. Overall concordance between patient and parent reports was moderate (70–75 %). No consistent pattern of child under- or over-reporting in comparison to the parent report was observed.

CONCLUSION

These study results identify concepts and vocabulary to inform item generation for a new pediatric self-report measure of cGVHD symptoms for use in clinical research. The findings also confirm the prevalence and nature of symptom distress in pediatric patients with cGVHD and support implementation of systematic approaches to symptom assessment and intervention in routine clinical practice.

摘要

目的

慢性移植物抗宿主病(cGVHD)是异基因造血细胞移植后死亡和发病的重要原因,并与广泛的痛苦症状有关。需要一种儿科 cGVHD 相关症状的衡量标准来推进临床研究。我们的目的是直接从儿童那里获取 cGVHD 症状体验的描述,并比较儿童用于描述其症状的特定语言,以及跨发育范围对症状概念的理解。

方法

我们使用定性方法来识别患有 cGVHD 的儿童(年龄为 5-8 岁[ n =8],9-12 岁[ n =8]和 13-17 岁[ n =8])在描述其症状时使用的短语、术语和结构。通过对每位参与者及其父母(5-7 岁的儿童与父母一起接受访谈)进行单独访谈来确定每位参与者的症状体验。具有评估 cGVHD 经验的医疗保健专业人员对每位参与者进行临床评估。

结果

儿科移植幸存者及其父母确定了一系列令人烦恼的 cGVHD 症状,并且出现了描述这些症状的常见概念和术语。患者和父母的报告之间的总体一致性为中等(70-75%)。未观察到儿童报告低于或高于父母报告的一致模式。

结论

这些研究结果确定了概念和词汇,为使用于临床研究的新的儿科 cGVHD 症状自我报告衡量标准的项目生成提供信息。研究结果还证实了儿科 cGVHD 患者的症状困扰的普遍性和性质,并支持在常规临床实践中实施系统的症状评估和干预方法。

相似文献

1
Child and parent perspectives of the chronic graft-versus-host disease (cGVHD) symptom experience: a concept elicitation study.儿童和家长对慢性移植物抗宿主病(cGVHD)症状体验的看法:一项概念发掘研究。
Support Care Cancer. 2014 Feb;22(2):295-305. doi: 10.1007/s00520-013-1957-6.
2
Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews.通过认知访谈评估的李氏慢性移植物抗宿主病症状量表的内容效度
Biol Blood Marrow Transplant. 2016 Apr;22(4):752-758. doi: 10.1016/j.bbmt.2015.12.026. Epub 2016 Jan 2.
3
Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.慢性移植物抗宿主病对造血细胞移植幸存者健康状况的影响:来自骨髓移植幸存者研究的报告
Blood. 2006 Oct 15;108(8):2867-73. doi: 10.1182/blood-2006-02-003954. Epub 2006 Jun 20.
4
"They knew the same struggles": perceptions of a group coping skills intervention in patients with chronic graft-versus-host disease.“他们经历着同样的挣扎”:对慢性移植物抗宿主病患者群体应对技能干预的认知
Support Care Cancer. 2025 Jan 16;33(2):102. doi: 10.1007/s00520-025-09153-x.
5
Health-related quality of life in pediatric patients after allogeneic SCT: development of the PedsQL Stem Cell Transplant module and results of a pilot study.异基因造血干细胞移植后儿科患者的健康相关生活质量:儿童生活质量量表干细胞移植模块的开发及一项试点研究的结果
Bone Marrow Transplant. 2014 Aug;49(8):1093-7. doi: 10.1038/bmt.2014.96. Epub 2014 May 12.
6
Psychological and physical function in allogeneic hematopoietic cell transplant survivors with chronic graft-versus-host disease.异基因造血细胞移植后慢性移植物抗宿主病患者的心理和生理功能。
J Cancer Surviv. 2023 Jun;17(3):646-656. doi: 10.1007/s11764-023-01354-9. Epub 2023 Mar 14.
7
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part IV. Patient Important Outcomes.儿科移植与细胞治疗协会造血细胞移植后小儿慢性移植物抗宿主病生存的RESILIENT会议:第四部分。患者重要结局。
Transplant Cell Ther. 2025 Apr;31(4):224.e1-224.e13. doi: 10.1016/j.jtct.2024.12.019. Epub 2024 Dec 27.
8
Development and psychometric testing of a pediatric chronic graft-versus-host disease symptom scale: protocol for a two-phase, mixed methods study.儿童慢性移植物抗宿主病症状量表的开发与心理测量测试:一项两阶段混合方法研究的方案
Front Psychol. 2024 Jan 8;14:1243005. doi: 10.3389/fpsyg.2023.1243005. eCollection 2023.
9
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part III. Long-Term Impact of Chronic Graft-versus-Host Disease on Endocrinologic, Cardiovascular, and Metabolic Outcomes in Survivors of Pediatric Hematopoietic Cell Transplantation.儿科移植与细胞治疗联盟造血细胞移植后小儿慢性移植物抗宿主病幸存者的RESILIENT会议:第三部分。慢性移植物抗宿主病对小儿造血细胞移植幸存者内分泌、心血管和代谢结局的长期影响。
Transplant Cell Ther. 2025 May;31(5):297.e1-297.e15. doi: 10.1016/j.jtct.2025.01.891. Epub 2025 Feb 12.
10
Graft-Versus-Host-Disease and Health-Related Quality of Life in Young Long-term Survivors of Cancer and Allogeneic Hematopoietic Stem Cell Transplantation.移植物抗宿主病与癌症和异基因造血干细胞移植后长期生存的年轻人的健康相关生活质量。
J Adolesc Young Adult Oncol. 2023 Feb;12(1):66-75. doi: 10.1089/jayao.2021.0196. Epub 2022 May 11.

引用本文的文献

1
Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-Versus-Host Disease Survivorship After Hematopoietic Cell Transplantation: Part IV. Patient Important Outcomes.儿科移植与细胞治疗协会造血细胞移植后小儿慢性移植物抗宿主病生存的RESILIENT会议:第四部分。患者重要结局。
Transplant Cell Ther. 2025 Apr;31(4):224.e1-224.e13. doi: 10.1016/j.jtct.2024.12.019. Epub 2024 Dec 27.
2
Development and psychometric testing of a pediatric chronic graft-versus-host disease symptom scale: protocol for a two-phase, mixed methods study.儿童慢性移植物抗宿主病症状量表的开发与心理测量测试:一项两阶段混合方法研究的方案
Front Psychol. 2024 Jan 8;14:1243005. doi: 10.3389/fpsyg.2023.1243005. eCollection 2023.
3

本文引用的文献

1
Pediatric patient-reported outcome instruments for research to support medical product labeling: report of the ISPOR PRO good research practices for the assessment of children and adolescents task force.支持医疗产品标签的研究用儿科患者报告结局测评工具:ISPOR PRO 评估儿童和青少年实践良好研究报告工具专题组报告。
Value Health. 2013 Jun;16(4):461-79. doi: 10.1016/j.jval.2013.04.004.
2
Comparison between patient-reported and clinician-observed symptoms in oncology.肿瘤患者报告症状与临床医生观察症状的比较。
Cancer Nurs. 2013 Nov-Dec;36(6):E1-E16. doi: 10.1097/NCC.0b013e318269040f.
3
Correlation between NIH composite skin score, patient-reported skin score, and outcome: results from the Chronic GVHD Consortium.
Including Young Children in the Development and Testing of Patient Reported Outcome (PRO) Instruments: A Scoping Review of Children's Involvement and Qualitative Methods.将儿童纳入患者报告结局(PRO)工具的开发和测试中:儿童参与和定性方法的范围综述。
Patient. 2023 Sep;16(5):425-456. doi: 10.1007/s40271-023-00637-8. Epub 2023 Jul 4.
4
Checking IN: Development, Acceptability, and Feasibility of a Pediatric Electronic Distress Screener.入住检查:儿科电子遇险筛查仪的开发、可接受性和可行性
Clin Pract Pediatr Psychol. 2023 Mar;11(1):94-107. doi: 10.1037/cpp0000450. Epub 2022 Aug 11.
5
Readability of Online Patient Education Materials for Graft-Versus-Host Disease.移植物抗宿主病在线患者教育材料的可读性。
J Cancer Educ. 2023 Aug;38(4):1363-1366. doi: 10.1007/s13187-023-02271-2. Epub 2023 Feb 16.
6
Social Support, Coping, and Cancer-Related Health Burden in Long-term Survivors Treated with Hematopoietic Stem Cell Transplantation as Adolescents or Young Adults.青少年或青年时期接受造血干细胞移植治疗的长期幸存者的社会支持、应对方式和与癌症相关的健康负担。
J Adolesc Young Adult Oncol. 2023 Aug;12(4):496-502. doi: 10.1089/jayao.2022.0105. Epub 2022 Oct 25.
7
Symptom burden trajectories experienced by patients with brain tumors.脑肿瘤患者经历的症状负担轨迹。
Cancer. 2020 Jul 15;126(14):3341-3351. doi: 10.1002/cncr.32879. Epub 2020 May 6.
8
EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.EBMT-NIH-CIBMTR 工作组关于移植物抗宿主病评估标准化术语和指导的立场声明。
Bone Marrow Transplant. 2018 Nov;53(11):1401-1415. doi: 10.1038/s41409-018-0204-7. Epub 2018 Jun 5.
9
Patient and Caregiver Adjustment to Hematopoietic Stem Cell Transplantation: a Systematic Review of Dyad-Based Studies.患者及照料者对造血干细胞移植的适应情况:基于二元组研究的系统评价
Curr Hematol Malig Rep. 2017 Aug;12(4):324-334. doi: 10.1007/s11899-017-0391-0.
10
Measuring therapeutic response in chronic graft-versus-host disease. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. The 2014 Response Criteria Working Group report.慢性移植物抗宿主病治疗反应的评估。美国国立卫生研究院慢性移植物抗宿主病临床试验标准共识发展项目:IV。2014年反应标准工作组报告。
Biol Blood Marrow Transplant. 2015 Jun;21(6):984-99. doi: 10.1016/j.bbmt.2015.02.025. Epub 2015 Mar 19.
NIH 综合皮肤评分、患者报告皮肤评分与结局的相关性:慢性移植物抗宿主病联盟研究结果。
Blood. 2012 Sep 27;120(13):2545-52; quiz 2774. doi: 10.1182/blood-2012-04-424135. Epub 2012 Jul 6.
4
Clinical benefit of response in chronic graft-versus-host disease.慢性移植物抗宿主病反应的临床获益。
Biol Blood Marrow Transplant. 2012 Oct;18(10):1517-24. doi: 10.1016/j.bbmt.2012.05.016. Epub 2012 Jun 6.
5
Successful implementation of cognitive interviews in special populations.认知访谈在特殊人群中的成功实施。
Expert Rev Pharmacoecon Outcomes Res. 2012 Apr;12(2):181-7. doi: 10.1586/erp.11.103.
6
Content validity--establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO good research practices task force report: part 1--eliciting concepts for a new PRO instrument.内容效度——在新开发的用于医疗产品评估的患者报告结局(PRO)工具中建立和报告证据:ISPOR PRO 良好研究实践工作组报告:第 1 部分——为新 PRO 工具征集概念。
Value Health. 2011 Dec;14(8):967-77. doi: 10.1016/j.jval.2011.06.014. Epub 2011 Oct 13.
7
Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease.与慢性移植物抗宿主病患儿非复发死亡率增加及总体生存率较差相关的危险因素。
Blood. 2011 Oct 20;118(16):4472-9. doi: 10.1182/blood-2011-04-349068. Epub 2011 Aug 30.
8
Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria.根据 2005 年 NIH 共识标准的全球和器官特异性慢性移植物抗宿主病严重程度。
Blood. 2011 Oct 13;118(15):4242-9. doi: 10.1182/blood-2011-03-344390. Epub 2011 Jul 26.
9
Qualitative research and content validity: developing best practices based on science and experience.定性研究和内容效度:基于科学和经验制定最佳实践。
Qual Life Res. 2009 Nov;18(9):1263-78. doi: 10.1007/s11136-009-9540-9. Epub 2009 Sep 27.
10
Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD).慢性移植物抗宿主病(cGVHD)的异基因造血干细胞移植长期幸存者的功能表现的决定因素。
Bone Marrow Transplant. 2010 Apr;45(4):762-9. doi: 10.1038/bmt.2009.238. Epub 2009 Sep 28.